Medicaid Prescription Drug Spending and Use
This issue paper provides the latest data and trend analysis on Medicaid prescription drug spending and utilization. In 2002, Medicaid programs spent $30 billion for prescribed drugs. Issue Paper (.pdf)
View the Latest: Prescription Drugs
Filter
-
-
Oregon’s Medicaid PDL: Will an Evidence-Based Formulary with Voluntary Compliance Set a Precedent for Medicaid?
ReportThis report is a case study of Oregon’s experience with its new prescription drug policy in its Medicaid fee-for-service pharmacy program. The report describes Oregon’s clinical review process, and assesses the results relative to other state preferred drug lists. Report (.pdf)
-
The Emerging Role of Group Medicare Private Fee-for-Service Plans
Issue BriefThis issue brief examines the recent boom in Medicare Advantage enrollment attributable to employers contracting with Private Fee-for-Service (PFFS) plans to cover their Medicare-eligible retirees. Between 2006 and 2008, the number of Medicare beneficiaries enrolled in Medicare Advantage group plans nearly doubled from 900,000 to nearly 1.7 million as of June 2008; most of this growth is attributable to contracts between employers and PFFS plans. The issue brief, prepared for the Foundation by Avalere Health,…
-
Tracking Poll Finds Seniors Split on Medicare Drug Benefit
Poll FindingTracking Poll Finds Seniors Now Split on Medicare Drug Benefit This August tracking survey shows modest progress in seniors' knowledge about the Medicare drug benefit. Also, for the first time, the tracking poll shows seniors are as likely to say that they have a favorable impression of the drug benefit as an unfavorable one. The Kaiser Health Poll Report Survey was conducted and analyzed by researchers at the Kaiser Family Foundation. A nationally representative sample…
-
Toplines: July/August 2005 Health Poll Report Survey
Poll FindingHealth News Index July/August, 2005 These toplines provide the complete survey questions and responses to the July/August 2005 Kaiser Health Poll Report, a bimonthly report designed to provide key tracking information on public opinion about health care topics to journalists, policymakers and the general public. It includes a series of questions on seniors' views and knowledge about the Medicare prescription drug benefit. Topline/Survey
-
An Implementation Perspective on Part D, the Medicare Prescription Drug Program
ReportThis focus group of 12 state Medicaid officials conducted in November 2005 explores the current status and likely results of the Part D dual eligible transition efforts as well as other Part D-related issues of particular importance to states. It includes discussion of the transition of dual eligibles from Medicaid to Medicare drug coverage, evaluating Part D plan options, states’ role in the low-income subsidy program, the fiscal implications of Part D to states, and…
-
Medicare Part D 2010 Data Spotlight: Benefit Design and Cost Sharing
ReportThe Medicare Modernization Act established a defined standard drug benefit for Part D stand-alone Prescription Drug Plans (PDPs) and Medicare Advantage Prescription Drug (MA-PD) plans, while giving plans flexibility to offer alternative benefit designs. Only about one in 10 PDPs offer the standard benefit in 2010. Plan sponsors can offer alternative benefit designs that are, at a minimum, actuarially equivalent to the defined standard and can also offer enhanced benefits. This Medicare Part D data…
-
Medicare Part D Data Spotlight: A First Look at Part D Plan Offerings in 2012
ReportThis data spotlight examines the stand-alone Part D drug plan options available to Medicare beneficiaries in 2012. Medicare beneficiaries will, on average, be able to choose from 31 stand-alone Medicare Part D prescription drug plans to choose from, a new Kaiser analysis finds. Average premiums would increase by 4 percent from 2011 to 2012 if beneficiaries remain with their current plans during the open enrollment period, which begins October 15 and December 31. That represents…
-
The Role of Part D for People With HIV/AIDS: Coverage and Cost of Antiretrovirals Under Medicare Drug Plans
Issue BriefThe Kaiser Family Foundation released a new report on the implications of the new Medicare Part D prescription drug benefit for people living with HIV/AIDS. The report looks at the coverage and cost of antiretroviral drugs under the new private, stand-alone Medicare drug plans. Report (.pdf)
-
Designing a Medicare Drug Discount Card: Implications of Policy Choices for Medicare Beneficiaries and Plan Sponsors
ReportThis report analyzes key issues surrounding the implementation of a Medicare-endorsed prescription drug discount card program. Medicare prescription drug discount cards have been proposed as a short-term strategy for lowering prescription drug costs for Medicare beneficiaries. The report considers the implications for both discount card sponsors and beneficiaries of alternative program designs, including such features as the annual lock-in for consumers, exclusive formularies, providing comparative information to consumers about drug prices and discounts, administration of…